Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biomarker research in prostate cancer--towards utility, not futility.

Literature DB >> 21394176

Biomarker research in prostate cancer--towards utility, not futility.

Sheng Fei Oon¹, Stephen R Pennington, John M Fitzpatrick, R William G Watson.

Abstract

The identification of an appropriate clinical question is critical for any biomarker project. Despite rapid advances in technology, few biomarkers have been forthcoming for prostate cancer. This could be because the clinical questions under investigation have not actually originated from clinical practice. These clinical questions are difficult to identify in the complex and heterogeneous pathogenesis of prostate cancer. In this Review, we have developed a prostate cancer 'roadmap' to identify the aspects of prostate cancer that may be amenable to biomarker discovery and serve as a guide for future projects in prostate cancer biomarker research.

Entities: Disease

Mesh：

Substances：

Year: 2011 PMID： 21394176 DOI： 10.1038/nrurol.2011.11

Source DB: PubMed Journal: Nat Rev Urol ISSN： 1759-4812 Impact factor: 14.432

69 in total

1. Incidence of prostatic carcinoma in the elderly.

Authors: I Rullis; J A Shaeffer; O M Lilien
Journal: Urology Date: 1975-09 Impact factor: 2.649

Review 2. Current practice of Gleason grading of prostate carcinoma.

Authors: Antonio Lopez-Beltran; Gregor Mikuz; Rafael J Luque; Roberta Mazzucchelli; Rodolfo Montironi
Journal: Virchows Arch Date: 2005-11-23 Impact factor: 4.064

3. The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

Authors: Burkhard Helpap; Lars Egevad
Journal: Virchows Arch Date: 2006-11-08 Impact factor: 4.064

4. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience.

Authors: Chao-Yu Hsu; Steven Joniau; Raymond Oyen; Tania Roskams; Hein Van Poppel
Journal: Eur Urol Date: 2006-06-09 Impact factor: 20.096

5. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Authors: M W Kattan; J A Eastham; A M Stapleton; T M Wheeler; P T Scardino
Journal: J Natl Cancer Inst Date: 1998-05-20 Impact factor: 13.506

6. 5A prospective survey of current prostate biopsy practices among oncological urologists.

Authors: Simon Brewster; Levent Turkeri; Maurizio Brausi; Vincent Ravery; Bob Djavan
Journal: Can J Urol Date: 2010-04 Impact factor: 1.344

7. Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy.

Authors: T Y Chan; A W Partin; P C Walsh; J I Epstein
Journal: Urology Date: 2000-11-01 Impact factor: 2.649

8. Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men.

Authors: Sang E Lee; Dae S Kim; Won K Lee; Hong Z Park; Chang J Lee; Seung H Doo; Seong J Jeong; Cheol Y Yoon; Seok-Soo Byun; Gheeyoung Choe; Sung I Hwang; Hak J Lee; Sung K Hong
Journal: BJU Int Date: 2009-11-13 Impact factor: 5.588

9. Validation of the partin nomogram for prostate cancer in a national sample.

Authors: James B Yu; Danil V Makarov; Richa Sharma; Richard E Peschel; Alan W Partin; Cary P Gross
Journal: J Urol Date: 2010-01 Impact factor: 7.450

10. Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials.

Authors: Elisabeth Eckersberger; Julia Finkelstein; Helen Sadri; Markus Margreiter; Samir S Taneja; Herbert Lepor; Bob Djavan
Journal: Rev Urol Date: 2009

16 in total

1. John Fitzpatrick: an appreciation.

Authors: William Watson; Mark Lawler
Journal: Oncologist Date: 2015-01

2. Targeting Fibronectin for Cancer Imaging and Therapy.

Authors: Zheng Han; Zheng-Rong Lu
Journal: J Mater Chem B Date: 2016-12-01 Impact factor: 6.331

3. Prostate Cancer Detection Using Composite Impedance Metric.

Authors: Shadab Khan; Aditya Mahara; Elias S Hyams; Alan R Schned; Ryan J Halter
Journal: IEEE Trans Med Imaging Date: 2016-06-09 Impact factor: 10.048

Review 4. Aberrant PSA glycosylation--a sweet predictor of prostate cancer.

Authors: Sarah Gilgunn; Paul J Conroy; Radka Saldova; Pauline M Rudd; Richard J O'Kennedy
Journal: Nat Rev Urol Date: 2013-01-15 Impact factor: 14.432

5. Highly efficient binding of paramagnetic beads bioconjugated with 100,000 or more antibodies to protein-coated surfaces.

Authors: Vigneshwaran Mani; Dhanuka P Wasalathanthri; Amit A Joshi; Challa V Kumar; James F Rusling
Journal: Anal Chem Date: 2012-11-13 Impact factor: 6.986

Review 6. Molecular tracing of prostate cancer lethality.

Authors: Yuanshuo Alice Wang; John Sfakianos; Ashutosh K Tewari; Carlos Cordon-Cardo; Natasha Kyprianou
Journal: Oncogene Date: 2020-10-12 Impact factor: 9.867

7. Automated 3D-Printed Microfluidic Array for Rapid Nanomaterial-Enhanced Detection of Multiple Proteins.

Authors: Karteek Kadimisetty; Spundana Malla; Ketki S Bhalerao; Islam M Mosa; Snehasis Bhakta; Norman H Lee; James F Rusling
Journal: Anal Chem Date: 2018-05-31 Impact factor: 6.986

8. Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer.

Authors: Alisa J Prager; Cynthia R Peng; Elena Lita; Debbie McNally; Aradhana Kaushal; Mary Sproull; Kathryn Compton; William L Dahut; William D Figg; Deborah Citrin; Kevin A Camphausen
Journal: Biomark Med Date: 2013-12 Impact factor: 2.851

9. The accuracy of magnetic resonance imaging in prostate cancer staging: a single-institution experience.

Authors: S F Oon; S P Power; J S Kelly; V McDermott; P Ryan; P C Ryan
Journal: Ir J Med Sci Date: 2014-04-06 Impact factor: 1.568

10. Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancer.

Authors: Yang Deng; Kunlin Xie; Christopher J Logothetis; Timothy C Thompson; Jeri Kim; Maosheng Huang; David W Chang; Jian Gu; Xifeng Wu; Yuanqing Ye
Journal: Carcinogenesis Date: 2020-08-12 Impact factor: 4.944